Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 121

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 121
---
 the actual sales of Depositary Shares or the mere existence of our arrangement with the Selling Shareholder may make it
more difficult for us to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish
to effect such sales.

Because the purchase price
per share to be paid by the Selling Shareholder for the Depositary Shares that we may elect to sell to the Selling Shareholder under the
Purchase Agreement, if any, will fluctuate based on the market prices of our Depositary Shares at the time we make such election, as of
the date of this prospectus, it is not possible for us to predict the number of Depositary Shares that we will sell to the Selling Shareholder
under the Purchase Agreement, the actual purchase price per share to be paid by the Selling Shareholder for those Depositary Shares, or
the actual gross proceeds to be raised by us from those sales, if any. As of January 15, 2025, there were 6,685,918,922 Ordinary Shares
outstanding. If all of the 358,750,000,000 Depositary Shares offered for resale by the Selling Shareholder under this prospectus were
issued and outstanding as of January 15, 2025, such shares would represent approximately 98.2% of total number of Ordinary Shares outstanding.
The actual number of Depositary Shares issuable will vary depending on the then current market price of shares of our Depositary Shares
sold to the Selling Shareholder in this offering.

The number of Depositary Shares
ultimately offered for sale by the Selling Shareholder for resale under this prospectus is dependent upon the number of Depositary Shares,
if any, we ultimately sell to the Selling Shareholder under the Purchase Agreement. Further, if and when we elect to sell Depositary Shares
to the Selling Shareholder pursuant to the Purchase Agreement, after the Selling Shareholder has acquired such shares, the Selling Shareholder
may resell all, some or none of such Depositary Shares at any time or from time to time in its discretion and at different prices.

The issuance of our Depositary
Shares to the Selling Shareholder pursuant to the Purchase Agreement will not affect the rights or privileges of our existing shareholders,
except that the economic and voting interests of each of our existing shareholders will be diluted. Although the number of Depositary
Shares that our existing shareholders own will not decrease, the Depositary Shares (and the underlying Ordinary Shares) owned by our existing